Clinical trial / 2014
Baru almond supplementation lowered total and LDL cholesterol in mildly hypercholesterolemic adults.
In a randomized crossover trial, 20 adults with mild hypercholesterolemia received 20 g/day of baru almonds or placebo capsules for two 6-week periods. Compared to placebo, baru almond intake decreased total cholesterol by 8.1 ± 2.4% (P = 0.007) and LDL cholesterol by 9.4 ± 2.4% (P = 0.006). No significant changes occurred in evaluated oxidation biomarkers.
- Study type
- Randomized crossover trial
- Who was studied
- 20 adults with mild hypercholesterolemia
- What was measured
- Serum lipid profile and oxidation biomarkers
THE PAPER
Baru almond improves lipid profile in mildly hypercholesterolemic subjects: a randomized, controlled, crossover study.
Bento AP, Cominetti C, Simões Filho A, Naves MM. Nutr Metab Cardiovasc Dis, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.